Armed antibodies and targeted cytotoxics for the treatment of cancer and of rheumatoid arthritis: from the bench to the clinic

Thumbnail

Event details

Date 01.12.2015
Hour 16:1518:00
Speaker Prof. Dario Neri, ETHZ
Location
Category Conferences - Seminars
The research of the group Neri focuses on the engineering of therapeutic antibodies for the treatment of cancer and of chronic inflammatory conditions. Other research activities include the development of DNA-encoded chemical libraries and of small molecule-drug conjugates. Furthermore, the group uses mass spectrometry methodologies for the discovery of vascular markers of disease and for HLA peptidome analysis.

Bio: Born in Rome (Italy) on 1 May 1963, Dario Neri studied Chemistry at the Scuola Normale Superiore of Pisa, graduating with a thesis on the synthesis and characterization of complex polyunsaturated secondary metabolites, isolated from higher plants. He earned his doctorate in Chemistry under the supervision of Prof. Dr. Kurt Wüthrich at the Institute of Molecular Biology and Biophysics of the ETH Zürich in 1992, receiving the Silver Medal of ETH Zürich for his dissertation.

With an EU Bridge Bursary, Dario Neri worked from 1992 until 1996 at the Cambridge Centre for Protein Engineering, Medical Research Council Centre,  under the supervision of Sir Gregory Winter. He has now been a Professor at the ETH Zurich since 1996.

Practical information

  • Informed public
  • Free

Organizer

  • NCCR Chemical Biology - Prof. Christian Heinis (LPPT)

Tags

biomacromolecules rheumatoid arthritis cancer immunology protein engineering chemistry antibodies

Event broadcasted in

Share